(NYSE MKT LLC: DXR) New York, NY, February 27, 2015 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, will be filing a Form N-CSR today disclosing its schedule of portfolio holdings as of December 31, 2014. Copies of the form will be mailed to the Company’s shareholders and […]
Major Research Presented and Published at the Critical Care Congress in Phoenix, Arizona, Utilizing the Daxor BVA-100 Blood Volume Analyzer A study on 50 patients with severe sepsis published in the journal Critical Care Medicine, Volume 42, No.12, December 2014, entitled Central Venous Pressure: Is It An Accurate Reflection of Intravascular Volume Status? analyzed whether central venous […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.